AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimidin M 2mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Axodin Pharmaceuticals Pvt. Ltd.

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimidin M 2mg/500mg Tablet ER

Diabetic patients with type 2 mellitus may benefit from the extended-release formulation of Glimepiride/Metformin 2mg/500mg tablets, a dual-action antidiabetic medication. This combination therapy effectively manages blood glucose levels in adults. Administer this medication with food, consistently at the same time daily for optimal results. Dosage will be personalized by your physician and adjusted based on your glycemic response. Continuous use is crucial; discontinuation without medical consultation risks hyperglycemia, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication forms one element of a comprehensive diabetes management plan, also requiring a balanced diet, regular physical activity, and appropriate weight management, as recommended by your healthcare provider. Lifestyle modifications significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms including diaphoresis, vertigo, cephalalgia, and tremors. Learn to recognize and manage these symptoms; maintain regular meal schedules and always carry a rapid-acting glucose source (e.g., glucose tablets, fruit juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential adverse reactions include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated for patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should discuss use with their physician. Consult your doctor prior to initiating this medication if you are pregnant or breastfeeding. Regular blood glucose monitoring is essential, and your doctor might order additional blood tests to evaluate blood cell counts and liver function.

Primary Ingredients of Glimidin M 2mg/500mg Tablet ER

The provided text is "undefined," which lacks meaning and cannot be rephrased.

Uses of Glimidin M 2mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glimidin M 2mg/500mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or breaking it. The Glimidin M 2mg/500mg Extended-Release tablet should be administered with a meal.

Common Side effects of Glimidin M 2mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimidin M 2mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimidin M 2mg/500mg Extended-Release tablet whole; do not fracture, pulverize, or chew it. Administer this medication with a meal.

How Glimidin M 2mg/500mg Tablet ER works:

Glimepiride/Metformin Extended-Release tablets (2mg/500mg) combine two distinct antidiabetic agents to manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, impeding intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimidin M 2mg/500mg Extended-Release tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimidin M 2mg/500mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Glimidin M 2mg/500mg tablets are contraindicated during lactation. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimidin M 2mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimidin M 2mg/500mg Extended-Release tablets. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimidin M 2mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiation should be at a low dose; however, the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimidin M 2mg/500mg Tablet ER :

Should you forget to take a Glimidin M 2mg/500mg Extended-Release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimidin M 2mg/500mg Tablet ER

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimidin M 2mg/500mg Tablet ER

Maintain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and other individuals.
Glimidin M 2mg/500mg Tablet ER carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is particularly concerning for individuals with impaired kidney function, the elderly, or those who consume substantial alcohol. Symptoms such as muscle aches, weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or a slow pulse warrant immediate discontinuation of Glimidin M 2mg/500mg Tablet ER and prompt medical attention.
Glimepiride and Metformin, combined as Glimidin M 2mg/500mg Extended-Release tablets, manage type 2 diabetes mellitus in adults. This dual therapy enhances glycemic control when used alongside a healthy diet and physical activity. Glimepiride stimulates pancreatic insulin secretion, thereby reducing blood sugar. Metformin acts by decreasing hepatic glucose output and boosting insulin responsiveness. This formulation is unsuitable for type 1 diabetes management.
Glimidin M 2mg/500mg Extended-Release tablets may cause common adverse events including low blood sugar, taste changes, nausea, abdominal discomfort, diarrhea, and headache. Rare but potentially severe reactions such as lactic acidosis may occur. Prolonged treatment may result in vitamin B12 deficiency.
Indeed, prolonged use of Glimidin M 2mg/500mg Extended-Release tablets can lead to Vitamin B12 deficiency. This medication impairs the body's ability to absorb Vitamin B12. Untreated deficiency can result in anemia, neurological complications such as tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and impaired coordination. To mitigate these risks, supplemental Vitamin B12 is recommended by some studies at least annually.
Indeed, Glimidin M 2mg/500mg Extended-Release tablets can lead to hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar may encompass nausea, headache, irritability, increased hunger, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The likelihood of hypoglycemia increases with skipped or delayed meals, alcohol consumption, strenuous physical activity, or concomitant use of other antidiabetic medications. Consequently, regular blood glucose monitoring is crucial. It is advisable to always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Combining Glimidin M 2mg/500mg extended-release tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimidin M 2mg/500mg Tabl...
56
MRP 68
18% off